Reliq Health Technologies Inc V.RHT

RHT HIRES LYTHAM PARTNERS AS INVESTOR RELATIONS PROG.

[Humanist]

Reliq Health Technologies, Inc. Engages Lytham Partners to Lead U.S. Investor Relations Outreach Program
 
by @nasdaq on 7 Jan 2021, 08:00
   
HAMILTON, Ontario, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTCQB:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing digital health company that develops innovative Virtual Care software as a service (SaaS) solutions for the Community Healthcare market has retained Lytham Partners, LLC ("Lytham Partners") to lead a U.S. investor relations program.

For more than 20 years, Lytham Partners has been one of the industry’s leading investor relations firms in the U.S., having created one of the largest and most diverse networks of institutional investors, while creating a framework of best practices in all aspects of corporate and shareholder communications.

“We made significant progress in 2020 in the United States by increasing our penetration beyond our historical markets of Florida and South Texas,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “We are now working with clients across the U.S. and have a clear path to cashflow positive in Q1 2021. Given our recent progress and anticipated growth in 2021, we believe that this is an opportune time to increase awareness of our company within the U.S. investment community. We look forward to working with the team at Lytham Partners, which has a strong understanding of the healthcare technology space and a proven track record of helping public companies communicate their story to the largest and most relevant cross section of institutional investors."

Ben Shamsian, Vice President of Lytham Partners, said, "Given Reliq’s fast growing and diversified customer base across the United States, we believe the U.S. investment community will be interested to learn more about their unique value proposition and opportunities ahead to create value for shareholders. We look forward to introducing the Company to our platform of investors while keeping shareholders apprised of the developments taking place at the Company."

In connection with the engagement, Lytham Partners will be compensated USD $6,000 per month.

The Company also announces the granting of stock options under its Stock Option Plan to purchase an aggregate of 500,000 common shares of the Company at an exercise price of $0.415 per share for a five year term. The stock options were granted to the CFO of the Company pursuant to Reliq’s Stock Option Plan and the policies of the TSX Venture Exchange and vest over one year.


About Lytham Partners
For more than 20 years, Lytham Partners has been one of the country's leading investor relations firms, having created one of the industry's largest and most diverse networks of institutional investors, while creating a framework of best practices in all aspects of corporate and shareholder communications. In addition to their relationships with many of the industry's most respected institutional investors, Lytham Partners has spent the past two decades creating an integrated platform that allows its clients far reaching exposure to investors in a consistent and in-depth format. This platform is matched with a communications and positioning approach that is streamlined throughout press releases, conference calls, investor presentations, corporate profiles, and websites. For more information visit our website at www.lythampartners.com.
About Reliq Health
Reliq Health Technologies is a rapidly growing digital health company that specializes in developing innovative Virtual Care software as a service (SaaS) solutions for the Community Healthcare market. Reliq’s powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT, on the OTCQB as RQHTF and on the WKN as A2AJTB.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information please contact:
Company Contact
Investor Relations at [e-mail]
Lytham Partners, LLC
Ben Shamsian
New York | Phoenix
Telephone: [phone]
[e-mail]
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
 

[Canadian_101]

a rapidly growing digital health company that develops innovative Virtual Care software as a service (SaaS) solutions for the Community Healthcare marke........REALLY.....?????

[lscfa]

How about posting some damn no.s before hiring another IR firm. There's a risk of pumping the stock and then under-delivering again.  

[lscfa]

Reaching cash flow positive (whatever that means) is not enough to justify current share price.....   Patients 52,000 42,000 35,000 Rev @ $50 / mo 7,800,000 6,300,000 5,250,000 Gross margin 40%

[Humanist]

totally agree isfca! aslo about your other point hiring of hiring hte firm. thats why the NR i posted i higlighted how much theyr'e paying mthly, shares to CEO as well as no date when theyr'e expectedto reach cash flow.. (2021) thats 12 mths from now if they think smart investors are going to stick around till than without any other improvement and actual progress, they're dilusional

[lscfa]

NR says cash flow positive in Q1 2021 so assume March 31, 2021.    I'll believe it when I see it.    

[Humanist]

thx for the correction isfca my mistake. i guess in my head it registered as not for sure ( clear path)  that's why it registered as such i guess lol . i guess i am fed up with every nr that doesnt have clear statement, with dates and figures.. etc.. 

[theinvestor22]

I've found that many early stage SAAS companies tend to get valued based on a p/rev model, however, if you wish to go down the road you're travelling (which isn't necessarily a bad idea), then a few points are in order: 1. I don't see any forex adjustment.  Are you assuming CAD $50/patient/month? 2. You've clearly fudged the gross margin % to come up with the same bottom

[Aei773ou]

Again, both of you have an obsession in this type of number guesstimating game. Not a problem with me in any way for recreational purpose. Never take it as a serious investment tool for Reliq any time soon. The problem is in the data used as I pointed out their shortcoming in my previous post. That is why the market does not see eye to eye with your methology. In the future when this company

[aaaaaargh]

I fully understand how you came to your conclusion of #2, however I don't think he was showing how things would change with growth, rather was giving different possible scenarios... 

[lscfa]

exactly, the table is showing possible scenarios of gross margin because bloody mgmt has gone silent on this after bragging for years it was going to be 85+%. That no. is no longer realistic since they are now a hybrid business of software services and care management services which is labour intensive.  

[Aei773ou]

The calculation has some acedemic indication if the data are all fairly predictable. But they are not and will not be known until they show up in the financials. Also the greatest variants lie in the charging rates which vary on the services month to month and different contract agreement could have different revenue spread btw RHT and Clients.